Kennedy Announces Changed COVID Vaccination Recommendations for Healthy Children and Pregnant Women

U.S. Health Secretary Kennedy announces that COVID-19 vaccines are no longer recommended for healthy children and pregnant women, citing lack of clinical evidence and shifting policy strategies.
U.S. Health Secretary Robert F. Kennedy Jr. has recently declared that COVID-19 vaccinations are no longer advised for healthy children and pregnant women. This decision was communicated through a brief 58-second video shared on the social media platform X, where Kennedy indicated that COVID-19 shots have been removed from the CDC's official recommendations for these groups. The video did not feature CDC representatives, and officials from the CDC redirected inquiries to Kennedy and the Department of Health and Human Services.
Historically, U.S. health authorities, guided by infectious disease experts, have recommended annual COVID-19 booster shots for all Americans from 6 months of age and older. A CDC advisory panel is scheduled to meet in June to discuss vaccination strategies for the upcoming fall, with considerations including targeting high-risk populations and offering vaccination choices to lower-risk groups.
Kennedy, known for his opposition to vaccines before his appointment as health secretary, argued that there is a lack of clinical evidence supporting the need for annual booster shots for children. This stance diverges from ongoing recommendations and the guidance of many health authorities.
Prominent figures such as FDA Commissioner Dr. Marty Makary and NIH Director Dr. Jay Battacharya appeared in support of Kennedy’s position during the announcement.
This move aligns with recent efforts by Kennedy and other Dr. Anthony Fauci-administration appointees to restrict COVID-19 vaccine recommendations and tighten approval criteria. The FDA recently announced that routine COVID-19 vaccine approvals will be limited primarily to seniors and individuals with underlying health conditions, pending new research for healthy adults and children.
Questions remain about the timing of this decision and the factors influencing it, as officials from HHS have not issued specific explanations. The evolving landscape of COVID-19 vaccination policy continues to provoke debate among healthcare professionals and the public.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
UK Mothers Highlight Lack of Support During Down Syndrome Prenatal Screening Process
A UK study reveals significant gaps in support and information provided to expectant mothers during Down syndrome prenatal screening, highlighting the need for improved patient-centered care and communication.
New Hope for Rare Language Development Disorder: A Potential Therapeutic Breakthrough
A groundbreaking study from Heidelberg University Hospital uncovers a promising therapeutic target for FOXP1 syndrome, offering hope for treating language and developmental disorders through enzyme inhibition.



